Science Explorer Interactive view Map
Company · Ann Arbor · United States

Esperion Therapeutics (United States)

esperion.comROR OpenAlex
Research works
74
▲ 86% vs 2013–17
Citations
4k
54.7 per fractional work
Top-10% rate
28.2%
record average 16.5%
Open access
44%
world 28%

Not ranked overall: Esperion Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.71× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 3.96× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 4.05× its world share, 0 worksPharmacology, Toxico…Engineering: 0.05× its world share, 0 worksEngineeringMathematics: 4.19× its world share, 1 worksMathematicsMedicine: 3.72× its world share, 15 worksMedicineNursing: 1.06× its world share, 0 worksNursingBusiness, Management and Accounting: 0.12× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.67× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Mathematics, 4.2×. Every wedge is a field page.

Who are the top researchers at Esperion Therapeutics (United States)?

Ranked on the composite score, LeAnne T. Bloedon lead among researchers whose main affiliation is Esperion Therapeutics (United States).

  1. 1 LeAnne T. Bloedon United States · #527,204 worldwide 71 citations · 16 works
All ranked researchers at Esperion Therapeutics (United States)

Which keywords describe research at Esperion Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Statins, Clinical Trials, Cardiovascular Disease Prevention, C-Reactive Protein, Cholesterol-lowering, LDL Cholesterol and Atherosclerosis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 19 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Inflammation4▲ 8.0×18 topics
  2. Clinical Trials4▲ 24×5 topics
  3. Statins4▲ 223×2 topics
  4. Cardiovascular Disease Prevention3▲ 174×2 topics
  5. C-Reactive Protein3▲ 197×2 topics
  6. Cholesterol-lowering3▲ 310×1 topic
  7. LDL Cholesterol3▲ 405×1 topic
  8. Atherosclerosis3▲ 43×6 topics
  9. Metabolic Syndrome2▲ 14×9 topics
  10. Cardiovascular Disease2▲ 9.8×8 topics
  11. Cholesterol2▲ 62×3 topics
  12. Insulin Resistance2▲ 19×5 topics
  13. Diabetes2▲ 14×4 topics
  14. Obesity1▲ 8.3×6 topics
  15. Cancer1▲ 4.0×7 topics
  16. Oxidative Stress1▲ 3.3×5 topics
  17. Autoantibodies1▲ 23×2 topics
  18. Prognostic Factors1▲ 11×3 topics
  19. Quality of Life1▲ 3.4×2 topics

Which research topics does Esperion Therapeutics (United States) publish most on?

By volume in 2022–2025: Lipoproteins and Cardiovascular Health, Cancer Treatment and Pharmacology, Systemic Lupus Erythematosus Research and Diabetes, Cardiovascular Risks, and Lipoproteins.

Lipoproteins and Cardiov…3Lipoproteins and Cardiovascular Health: 3 fractional worksCancer Treatment and Pha…1Cancer Treatment and Pharmacology: 1 fractional worksSystemic Lupus Erythemat…1Systemic Lupus Erythematosus Research: 1 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 1 fractional worksChronic Lymphocytic Leukemia Research: 1 fractional worksHIV-related health compl…1HIV-related health complications and treatments: 1 fractional worksAtherosclerosis and Cardiovascular Diseases: 0 fractional worksCholesterol and Lipid Metabolism: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional worksDrug Transport and Resistance Mechanisms: 0 fractional works
SurgeryOncologyRheumatologyEndocrinology, Diabetes and Metabolism4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lipoproteins and Cardiovascular Health Surgery 3 works
  2. 2 Cancer Treatment and Pharmacology Oncology 1 works
  3. 3 Systemic Lupus Erythematosus Research Rheumatology 1 works
  4. 4 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
  5. 5 Chronic Lymphocytic Leukemia Research Genetics 1 works
  6. 6 HIV-related health complications and treatments Emergency Medicine 1 works
  7. 7 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
  8. 8 Cholesterol and Lipid Metabolism Surgery 0 works
  9. 9 Cancer, Lipids, and Metabolism Cancer Research 0 works
  10. 10 Drug Transport and Resistance Mechanisms Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.1%not open55.9%

World: 28% of research is openly available.

with international co-authors33.2%domestic only66.8%

World: 19% is written across borders.

How has Esperion Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 86% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Ann Arbor

All research institutions in Ann Arbor

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.